Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor

PDA Journal of Pharmaceutical Science and Technology

Volumn 50, Issue 3, 1996, Pages 163-171

  Knepp, Victoria M ^a,b   Whatley, John L ^a,c   Muchnik, Anna ^a,b   Calderwood, Thomas S ^a,d  

^a ROCHE BIOSCIENCE   (United States)

^b ALZA CORPORATION   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d Athena Neurosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BISULFITE; CILIARY NEUROTROPHIC FACTOR; CYSTEINE; GALLIC ACID PROPYL ESTER; GLUTATHIONE; METHIONINE; RECOMBINANT NERVE GROWTH FACTOR; THIOL DERIVATIVE;

ARTICLE; AUTOOXIDATION; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; OXIDATION; PEPTIDE MAPPING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION;

ANTIOXIDANTS; CILIARY NEUROTROPHIC FACTOR; HUMANS; HYDROGEN PEROXIDE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; RECOMBINANT PROTEINS;

EID: 0030004386     PISSN: 1076397X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. T. L. Donaldson, E. F. Boonstra, and J. M. Hammond, "Kinetics of protein denaturation at gas-liquid interfaces," J. Coll. Int. Sci., 74, 443 (1980).
2. A. F. Henson, J. R. Mitchell, and P. R. Musselwhite, "The surface coagulation of proteins during shaking," J. Coll. Int. Sci., 32, 162 (1970).
3. F. MacRitchie, "Proteins at interfaces," Adv. Prot. Chem., 32, 283 (1978).
4. H. W. Chang and E. Bock, "Pitfalls in the use of commercial nonionic detergents for the solubilization of integral membrane proteins: sulfhydryl oxidizing contaminants and their elimination," Anal. Biochem., 104, 112 (1980).
5. M. Lever, "Peroxides in detergents as interfering factors in biochemical analysis," Anal. Biochem., 83, 274 (1977).
6. J. Jaeger, K. Sorenson, and S. P. Wolff, "Peroxide accumulation in detergents," J. Biochem. Biophys. Methods, 29, 77 (1994).
7. M. Donbrow, E. Azaz, and A. Pillersdorf, "Autoxidation of polysorbates," J. Pham. Sci., 67, 1676 (1978).
8. T. H. Nguyen, J. Burnier, and W. Meng, "The kinetics of relaxin oxidation by hydrogen peroxide," Pharm. Res., 10, 1563 (1993).
9. 2 and the hydroxyl radical," Arch. Biochem. and Biophys., 285, 357 (1991).
10. R. A. Houghten, C. B. Glaser, and C. H. Li, "Human somatotropin, reaction with hydrogen peroxide," Arch. Biochem. and Biophys., 178, 350 (1977).
11. G. Hausdorf, K. Kruger, G. Kuttner, H. Holzhutter, C. Frommel, and W. E. Hohne, "Oxidation of a methionine residue in subtilisin-type proteinases by the hydrogen peroxide/borate system - an active site-directed reaction," Biochim. Biophys. Acta, 952, 20 (1987).
12. U. K. Laemmli, "Cleavage of structural proteins during the assembly of the head of Bacteriophage T4," Nature, 227, 680 (1970).
13. J. R. McDonald, C. Ko, D. Mismer, D. J. Smith, and F. Collins, "Expression and characterization of recombinant human ciliary neurotrophic factor from Escherichia coli," Biochem. Biophys. Acta, 1090, 70 (1991).
14. L. G. Armes and L. J. Foley, "The complete primary structure of pilin from Haemophilux influenzae type b strain Eagan," J. Protein Chem., 9, 45 (1990).
15. Y. J. Wang and M. A. Hanson, "Parenteral formulations of proteins and peptides: Stability and stabilizers," J. Parenter. Sci. Technol., 42, Suppl. 2S (1988).
16. D. M. Johnson and W. F. Taylor, "Degradation of Fenprostalene in Polyethylene Glycol 400 Solution," J. Pharm. Sci., 73, 1414 (1984).
17. J. W. McGinity, J. A. Hill, and A. L. La Via, "Influence of peroxide impurities in polyethylene glycols on drug stability," J. Pharm. Sci., 64, 356 (1975).
18. E. Azaz, M. Donbrow, and R. Hamburger, "Assay of micro-scale amounts of hydroperoxide and of iodine in aqueous non-ionic surfactant solutions by a spectrophotometric method," Analyst, 98, 663 (1973).
19. K. A. Connors, G. L. Amidon, and V. J. Stella, Chemical Stability of Pharmaceuticals - A handbook for pharmacists, 2nd edition, J. Wiley and Sons; New York, NY, 1986, 82.
20. J. Russell, J. Ness, M. Chopra, J. McMurray, and W. E. Smith, "The assessment of the HO: scavenging action of therapeutic agents," J. Pharm. and Biomed. Analysis, 12, 863 (1994).
21. G. Toennies and T. P. Callan, "Methionine studies III. A comparison of oxidative reactions of methionine, cysteine, and cystine. Determination of methionine by hydrogen peroxide oxidation," J. Biol. Chem., 129, 481 (1939).
22. S. Li, C. Schoneich, G. S. Wilson, and R. T. Borchardt, "Chemical pathways of peptide degradation. V. Ascorbic acid promotes rather than inhibits the oxidation of methionine to methionine sulfoxide in small model peptides," Pharm. Res., 10, 1572 (1993).
23. T. Higuchi and L. C. Schroeter, "Kinetics and mechanism of formation of sulfonate from epinephrine and bisulfite," J. Am. Chem. Soc., 82, 1904 (1960).
24. L. M. Kleinman, J. A. Tangrea, J. F. Gallelli, J. H. Brown, and E. Gross, "Quality control and drug analysis," Am. J. Hasp. Pharm., 30, 1054 (1973).
25. J. P. Barton, J. E. Packer, and R. J. Sims, "Kinetics of the reaction of hydrogen peroxide with cysteine and cysteamine," J. Chem. Soc. Perkin II, 1547 (1973).